Compare Organon Pharma Indonesia Tbk. (SCPI) vs Platinum Wahab Nusantara Tbk. (TGUK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Platinum Wahab Nusantara Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Platinum Wahab Nusantara Tbk. trades at Rp91 (market cap 296.43B, 11.14M 24h volume). The key difference: Platinum Wahab Nusantara Tbk. is far larger — about 2.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TGUK | |
|---|---|---|
Market Cap | 104.4B | 296.43B |
Volume | — | 11.14M |
Lot | — | 111.42K |
Turnover | — | 972.2M |
Average Price | — | 87.26 |
Value | — | 972.2M |
Indicative Equilibrium Price | — | 91 |
Indicative Equilibrium Volume | — | 47.08K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Platinum Wahab Nusantara Tbk.
PT Platinum Wahab Nusantara Tbk. (the Company) was established based on Deed No. 16 dated June 6, 2018 of Notary Dr. Sugih Haryati, S.H., M.Kn., notary in Kota Tangerang. The Company started its commercial activities since 2018, by operating under the trademarks of "Teguk".
Read more on TGUK →
